Mezzion Pharma Co Dionica Analiza dionice | Cijena dionice | Novosti | 140410.KQ | KR7140410002 |

Datum	Mezzion Pharma Co Cijena dionice
13. 11. 2024.	31.700,00 undefined
12. 11. 2024.	32.100,00 undefined
11. 11. 2024.	31.200,00 undefined
08. 11. 2024.	32.850,00 undefined
07. 11. 2024.	33.200,00 undefined
06. 11. 2024.	34.300,00 undefined
05. 11. 2024.	33.000,00 undefined
04. 11. 2024.	34.400,00 undefined
01. 11. 2024.	33.000,00 undefined
31. 10. 2024.	35.800,00 undefined
30. 10. 2024.	34.200,00 undefined
29. 10. 2024.	34.000,00 undefined
28. 10. 2024.	31.800,00 undefined
25. 10. 2024.	30.250,00 undefined
24. 10. 2024.	30.650,00 undefined
23. 10. 2024.	29.900,00 undefined
22. 10. 2024.	29.700,00 undefined
21. 10. 2024.	30.800,00 undefined
18. 10. 2024.	30.600,00 undefined
17. 10. 2024.	31.050,00 undefined
16. 10. 2024.	30.650,00 undefined

Datum	Mezzion Pharma Co Prihod	Mezzion Pharma Co EBIT	Mezzion Pharma Co Dobit
2023	31,72 milijardi undefined	−14,49 milijardi undefined	−12,73 milijardi undefined
2022	30,73 milijardi undefined	−23,33 milijardi undefined	−36,30 milijardi undefined
2021	26,65 milijardi undefined	−16,80 milijardi undefined	−13,60 milijardi undefined
2020	28,63 milijardi undefined	−7,53 milijardi undefined	−13,83 milijardi undefined
2019	17,92 milijardi undefined	−24,72 milijardi undefined	−23,25 milijardi undefined
2018	19,09 milijardi undefined	−21,93 milijardi undefined	−18,88 milijardi undefined
2017	5,59 milijardi undefined	−16,85 milijardi undefined	−14,88 milijardi undefined
2016	8,75 milijardi undefined	−7,22 milijardi undefined	−12,99 milijardi undefined
2015	14,93 milijardi undefined	−2,73 milijardi undefined	4,22 milijardi undefined
2014	4,86 milijardi undefined	−4,92 milijardi undefined	−2,57 milijardi undefined
2013	4,40 milijardi undefined	−2,47 milijardi undefined	−831,00 mil. undefined
2012	8,59 milijardi undefined	1,68 milijardi undefined	2,39 milijardi undefined
2011	5,07 milijardi undefined	2,93 milijardi undefined	3,20 milijardi undefined
2010	24,25 milijardi undefined	17,64 milijardi undefined	17,07 milijardi undefined
2009	18,44 milijardi undefined	12,97 milijardi undefined	11,57 milijardi undefined
2008	206,00 mil. undefined	−2,66 milijardi undefined	−2,23 milijardi undefined

	Prihod	EBIT	Dobit
2008	206,00 mil. KRW	−2,66 milijardi KRW	−2,23 milijardi KRW
2009	18,44 milijardi KRW	12,97 milijardi KRW	11,57 milijardi KRW
2010	24,25 milijardi KRW	17,64 milijardi KRW	17,07 milijardi KRW
2011	5,07 milijardi KRW	2,93 milijardi KRW	3,20 milijardi KRW
2012	8,59 milijardi KRW	1,68 milijardi KRW	2,39 milijardi KRW
2013	4,40 milijardi KRW	−2,47 milijardi KRW	−831,00 mil. KRW
2014	4,86 milijardi KRW	−4,92 milijardi KRW	−2,57 milijardi KRW
2015	14,93 milijardi KRW	−2,73 milijardi KRW	4,22 milijardi KRW
2016	8,75 milijardi KRW	−7,22 milijardi KRW	−12,99 milijardi KRW
2017	5,59 milijardi KRW	−16,85 milijardi KRW	−14,88 milijardi KRW
2018	19,09 milijardi KRW	−21,93 milijardi KRW	−18,88 milijardi KRW
2019	17,92 milijardi KRW	−24,72 milijardi KRW	−23,25 milijardi KRW
2020	28,63 milijardi KRW	−7,53 milijardi KRW	−13,83 milijardi KRW
2021	26,65 milijardi KRW	−16,80 milijardi KRW	−13,60 milijardi KRW
2022	30,73 milijardi KRW	−23,33 milijardi KRW	−36,30 milijardi KRW
2023	31,72 milijardi KRW	−14,49 milijardi KRW	−12,73 milijardi KRW

2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
0,21	18,44	24,25	5,07	8,59	4,40	4,86	14,93	8,75	5,59	19,09	17,92	28,63	26,65	30,73	31,72
-	8.852,91	31,50	−79,11	69,57	−48,77	10,34	207,31	−41,37	−36,17	241,71	−6,12	59,79	−6,92	15,28	3,24
1.885,44	21,06	16,01	100,00	74,30	56,72	50,28	65,85	56,72	16,09	16,96	16,19	25,98	13,87	−1,02	12,24
0	0	0	5,07	6,38	2,50	2,44	9,83	4,96	0,90	3,24	2,90	7,44	3,70	−0,31	3,88
−2,23	11,57	17,07	3,20	2,39	−0,83	−2,57	4,22	−12,99	−14,88	−18,88	−23,25	−13,83	−13,60	−36,30	−12,73
-	−619,02	47,58	−81,23	−25,56	−134,84	209,03	−264,45	−407,48	14,61	26,84	23,18	−40,52	−1,64	166,85	−64,93
8,00	8,00	8,00	6,00	8,00	7,00	8,00	8,00	7,00	7,00	8,00	9,00	9,00	26,69	26,73	28,24
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023

0,90	6,71	20,29	17,65	59,57	54,43	68,59	93,17	89,06	61,76	55,07	41,16	49,10	47,21	32,40	58,25
0,23	0,59	0,14	0,35	0	1,41	1,86	1,56	1,50	1,80	2,03	3,03	2,62	2,46	2,68	2,65
0,03	0,09	0	0	0	1,94	0,70	0,48	0,97	0,29	4,59	1,37	1,63	2,13	1,69	3,38
0	0	0	0	0	0,46	2,27	2,05	2,41	2,74	2,40	6,00	7,01	11,78	8,83	5,74
0,02	0,53	0,00	0,19	0,00	0,00	0,09	0,08	0,27	3,91	5,93	0,29	0,31	0,60	0,30	4,22
1,17	7,92	20,43	18,19	59,57	58,24	73,51	97,33	94,19	70,50	70,02	51,85	60,67	64,17	45,90	74,24
0,21	0,12	0,13	0,17	0,18	0,14	0,32	0,75	0,20	0,86	1,20	4,90	5,90	4,88	4,24	2,85
0	4,99	9,52	10,65	5,68	3,06	0	2,02	0	0	0	0	0	−0,00	−0,00	0,00
0	0	0	0	0	0	263,00	293,00	332,00	487,00	223,00	30,00	160,00	30,00	310,00	150,00
0	0	0,82	0,98	1,08	1,08	2,32	1,83	0,31	1,64	1,64	1,62	8,24	14,18	1,62	12,94
0	0	0	0	0	0	705,00	705,00	0	0	0	0	0	0	0	0
0,15	1,84	0,66	1,59	0,78	0,81	0,76	0,14	0,86	0,55	1,98	0,47	0,66	0,67	1,95	1,96
0,36	6,95	11,14	13,39	7,73	5,10	4,37	5,72	1,71	3,54	5,04	7,02	14,96	19,76	8,12	17,91
1,53	14,86	31,57	31,58	67,30	63,34	77,87	103,05	95,90	74,04	75,06	58,87	75,63	83,93	54,02	92,15

1,53	3,03	3,03	3,03	4,04	4,04	4,06	4,08	4,08	4,17	4,32	4,35	4,45	4,45	13,37	14,80
5,45	5,44	5,44	5,44	51,33	51,62	53,03	52,51	54,80	63,37	64,14	67,28	92,84	88,25	79,70	130,96
−11,72	−0,15	16,32	19,62	21,69	20,50	17,83	21,86	9,91	−5,13	−24,11	−47,35	−61,17	−74,79	−111,05	−123,72
0	0	0,04	0,08	−13,73	0,02	0	0,91	0,83	−0,54	14,22	18,55	20,69	44,88	44,22	39,41
0	−73,00	0	0	0	0	0	0	8,00	0	0	0	0	0	0	0
−4,74	8,25	24,83	28,17	63,34	76,18	74,91	79,35	69,63	61,88	58,56	42,83	56,81	62,79	26,24	61,44
0	0	0	0	0,69	0	0,01	2,24	3,44	2,47	2,99	3,57	3,47	5,50	7,17	4,03
0,10	0,24	0,17	0,10	0	0,08	0,28	0,12	0,84	4,92	7,64	7,85	5,53	7,19	11,47	21,83
0,57	2,34	4,32	1,27	2,26	0,06	10,42	11,35	12,20	4,93	6,87	0,91	4,52	3,82	5,35	2,52
1,50	0	0	0	0	0	0	0	0	0	0	0,43	0,99	0,93	1,06	0,50
0	0	0	0	0	0	0	0	0	8,18	0,24	0,75	1,02	1,05	1,03	0,74
2,16	2,59	4,49	1,36	2,95	0,14	10,70	13,72	16,48	20,49	17,74	13,51	15,51	18,50	26,08	29,62
0	0	0	0	0	0	0	25,24	26,26	0	0	2,42	3,10	2,34	1,62	1,01
0	0	0	0	0	0	0	147,00	354,00	376,00	0	0	0	0	0	0
4,10	4,03	2,25	2,05	1,02	1,03	1,02	1,41	0	0	0	0,11	0,20	0,31	0,08	0,08
4,10	4,03	2,25	2,05	1,02	1,03	1,02	26,80	26,61	0,38	0	2,53	3,30	2,64	1,70	1,09
6,27	6,61	6,74	3,41	3,97	1,16	11,72	40,52	43,09	20,87	17,74	16,04	18,82	21,14	27,78	30,70
1,53	14,86	31,57	31,58	67,30	77,34	86,64	119,87	112,72	82,75	76,30	58,88	75,63	83,93	54,02	92,15

2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022
−2,23	11,57	20,16	4,09	3,00	−0,52	−3,33	5,16	−12,99	−14,88	−18,88	−23,25	−13,83	−13,51	−36,30
0,07	0,10	0,10	0,04	0,05	0,05	0,15	0,34	0,41	0,06	0,23	1,33	1,43	1,59	1,66
0	−1.410,00	0	0	0	0	0	0	0	0	0	0	0	0	0
−0,17	0,60	−2,68	−3,09	1,90	−1,71	0,10	3,91	1,20	3,53	−1,43	−1,95	−2,93	−2,41	6,22
0,01	0,90	−0,50	−2,56	−1,81	−1,37	−1,42	−7,64	5,30	−1,93	−1,65	2,99	7,95	−0,74	16,35
0	0	0	0	0	0	0	0	547,00	478,00	375,00	878,00	9,00	7,00	26,00
0	0	0,72	3,12	0,22	0,81	−0,56	−0,06	−0,01	−0,19	0,22	2,28	0,13	1,53	0,40
−2,32	11,75	17,08	−1,52	3,14	−3,56	−4,50	1,77	−6,08	−13,21	−21,72	−20,88	−7,38	−15,07	−12,07
−180,00	−779,00	−25,00	−318,00	−165,00	−7,00	−251,00	−564,00	−169,00	−2.048,00	−572,00	−1.098,00	−7.956,00	−6.182,00	−1.761,00
−0,16	−5,93	−11,56	0,73	−26,57	13,62	−2,48	−0,98	−36,81	36,42	1,29	0,30	3,56	−16,33	17,41
0,02	−5,15	−11,53	1,04	−26,40	13,62	−2,23	−0,41	−36,64	38,47	1,86	1,40	11,52	−10,15	19,17
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	−1,50	0	0	0	0	0	42,00	−1,80	−23,70	−3,19	−1,04	22,99	−1,11	−0,93
0	1,49	0	0	32,90	0	6,90	−7,65	0	12,45	21,25	7,81	1,02	0,23	0,31
0	−0,01	0	0	32,90	−0,18	16,30	24,95	−1,80	−11,25	18,06	6,76	24,01	19,11	−0,62
0	0	0	0	0	0,01	9,40	−9,40	0	0	0	0	0	20,00	0
0	0	0	0	0	−182,00	0	0	0	0	0	0	0	0	0
−2,48	5,81	5,12	−0,75	9,03	9,69	9,44	26,11	−44,74	11,47	−2,52	−13,91	20,21	−11,64	5,19
−2.499,00	10.968,00	17.054,00	−1.840,00	2.971,00	−3.564,00	−4.753,00	1.208,00	−6.246,00	−15.262,00	−22.296,00	−21.978,00	−15.333,00	−21.253,95	−13.835,67
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Mezzion Pharma Co Bruto marža	Mezzion Pharma Co Marža dobiti	Mezzion Pharma Co EBIT marža	Mezzion Pharma Co Marža dobiti
2023	12,25 %	−45,68 %	−40,13 %
2022	−1,02 %	−75,93 %	−118,13 %
2021	13,88 %	−63,02 %	−51,03 %
2020	25,98 %	−26,30 %	−48,30 %
2019	16,19 %	−137,93 %	−129,75 %
2018	16,96 %	−114,87 %	−98,89 %
2017	16,09 %	−301,58 %	−266,42 %
2016	56,72 %	−82,50 %	−148,38 %
2015	65,85 %	−18,31 %	28,29 %
2014	50,28 %	−101,21 %	−52,87 %
2013	56,72 %	−56,18 %	−18,88 %
2012	74,30 %	19,55 %	27,76 %
2011	100,00 %	57,73 %	63,23 %
2010	12,25 %	72,75 %	70,40 %
2009	12,25 %	70,35 %	62,73 %
2008	12,25 %	−1.290,29 %	−1.082,04 %

	Bruto marža	EBIT marža	Marža dobiti
2008	12,25 %	−1.290,29 %	−1.082,04 %
2009	12,25 %	70,35 %	62,73 %
2010	12,25 %	72,75 %	70,40 %
2011	100,00 %	57,73 %	63,23 %
2012	74,30 %	19,55 %	27,76 %
2013	56,72 %	−56,18 %	−18,88 %
2014	50,28 %	−101,21 %	−52,87 %
2015	65,85 %	−18,31 %	28,29 %
2016	56,72 %	−82,50 %	−148,38 %
2017	16,09 %	−301,58 %	−266,42 %
2018	16,96 %	−114,87 %	−98,89 %
2019	16,19 %	−137,93 %	−129,75 %
2020	25,98 %	−26,30 %	−48,30 %
2021	13,88 %	−63,02 %	−51,03 %
2022	−1,02 %	−75,93 %	−118,13 %
2023	12,25 %	−45,68 %	−40,13 %

Datum	Mezzion Pharma Co Prihod po dionici	Mezzion Pharma Co EBIT po dionici	Mezzion Pharma Co Dobit po dionici
2023	1.123,31 undefined	−513,07 undefined	−450,74 undefined
2022	1.149,38 undefined	−872,76 undefined	−1.357,81 undefined
2021	998,73 undefined	−629,41 undefined	−509,70 undefined
2020	3.181,56 undefined	−836,78 undefined	−1.536,56 undefined
2019	1.991,11 undefined	−2.746,33 undefined	−2.583,44 undefined
2018	2.386,00 undefined	−2.740,75 undefined	−2.359,50 undefined
2017	798,00 undefined	−2.406,57 undefined	−2.126,00 undefined
2016	1.250,14 undefined	−1.031,43 undefined	−1.855,00 undefined
2015	1.865,75 undefined	−341,63 undefined	527,88 undefined
2014	607,13 undefined	−614,50 undefined	−321,00 undefined
2013	628,86 undefined	−353,29 undefined	−118,71 undefined
2012	1.074,00 undefined	210,00 undefined	298,13 undefined
2011	844,50 undefined	487,50 undefined	534,00 undefined
2010	3.031,63 undefined	2.205,50 undefined	2.134,25 undefined
2009	2.305,38 undefined	1.621,75 undefined	1.446,13 undefined
2008	25,75 undefined	−332,25 undefined	−278,63 undefined

	Prihod po dionici	EBIT po dionici	Dobit po dionici
2008	25,75 KRW	−332,25 KRW	−278,63 KRW
2009	2.305,38 KRW	1.621,75 KRW	1.446,13 KRW
2010	3.031,63 KRW	2.205,50 KRW	2.134,25 KRW
2011	844,50 KRW	487,50 KRW	534,00 KRW
2012	1.074,00 KRW	210,00 KRW	298,13 KRW
2013	628,86 KRW	−353,29 KRW	−118,71 KRW
2014	607,13 KRW	−614,50 KRW	−321,00 KRW
2015	1.865,75 KRW	−341,63 KRW	527,88 KRW
2016	1.250,14 KRW	−1.031,43 KRW	−1.855,00 KRW
2017	798,00 KRW	−2.406,57 KRW	−2.126,00 KRW
2018	2.386,00 KRW	−2.740,75 KRW	−2.359,50 KRW
2019	1.991,11 KRW	−2.746,33 KRW	−2.583,44 KRW
2020	3.181,56 KRW	−836,78 KRW	−1.536,56 KRW
2021	998,73 KRW	−629,41 KRW	−509,70 KRW
2022	1.149,38 KRW	−872,76 KRW	−1.357,81 KRW
2023	1.123,31 KRW	−513,07 KRW	−450,74 KRW

	Broj dionica
2008	8,00 mil. Aktien
2009	8,00 mil. Aktien
2010	8,00 mil. Aktien
2011	6,00 mil. Aktien
2012	8,00 mil. Aktien
2013	7,00 mil. Aktien
2014	8,00 mil. Aktien
2015	8,00 mil. Aktien
2016	7,00 mil. Aktien
2017	7,00 mil. Aktien
2018	8,00 mil. Aktien
2019	9,00 mil. Aktien
2020	9,00 mil. Aktien
2021	26,69 mil. Aktien
2022	26,73 mil. Aktien
2023	28,24 mil. Aktien

Datum	Mezzion Pharma Co Dividenda
2012	8,33 undefined

	Dividenda	Dividenda (procjena)
2008	0 KRW	0 KRW
2009	0 KRW	0 KRW
2010	0 KRW	0 KRW
2011	0 KRW	0 KRW
2012	8,33 KRW	0 KRW
2013	0 KRW	0 KRW
2014	0 KRW	0 KRW
2015	0 KRW	0 KRW
2016	0 KRW	0 KRW
2017	0 KRW	0 KRW
2018	0 KRW	0 KRW
2019	0 KRW	0 KRW
2020	0 KRW	0 KRW
2021	0 KRW	0 KRW
2022	0 KRW	0 KRW
2023	0 KRW	0 KRW

Datum	Mezzion Pharma Co Isplata dobiti
2023	2,80 %
2022	2,80 %
2021	2,80 %
2020	2,80 %
2019	2,80 %
2018	2,80 %
2017	2,80 %
2016	2,80 %
2015	2,80 %
2014	2,80 %
2013	2,80 %
2012	2,80 %
2011	2,80 %
2010	2,80 %
2009	2,80 %
2008	2,80 %

	Isplata dobiti
2008	2,80 %
2009	2,80 %
2010	2,80 %
2011	2,80 %
2012	2,80 %
2013	2,80 %
2014	2,80 %
2015	2,80 %
2016	2,80 %
2017	2,80 %
2018	2,80 %
2019	2,80 %
2020	2,80 %
2021	2,80 %
2022	2,80 %
2023	2,80 %

%	Ime	Dionice	Promjena	Datum
9,72220 %	CCE Investment Inc	2.913.093	0	30. 06. 2024.
6,66745 %	Kayne Holdings LP	1.997.787	0	30. 06. 2024.
6,16851 %	Park (Dong Hyeon)	1.848.290	0	30. 06. 2024.
2,86862 %	Kim (Hye Su)	859.533	0	30. 06. 2024.
2,56724 %	Glamor Box Limited	769.230	0	30. 06. 2024.
1,54088 %	The Vanguard Group, Inc.	461.699	4.814	30. 09. 2024.
1,09815 %	Samsung Asset Management Co., Ltd.	329.042	117	30. 09. 2024.
0,72122 %	BlackRock Institutional Trust Company, N.A.	216.102	913	30. 09. 2024.
0,39460 %	BlackRock Advisors (UK) Limited	118.234	8.552	30. 09. 2024.
0,31935 %	Mirae Asset Global Investments Co., Ltd.	95.689	2.186	31. 08. 2024.
0,20695 %	State Street Global Advisors (US)	62.010	−102	30. 09. 2024.
0,17207 %	Norges Bank Investment Management (NBIM)	51.558	−47.466	30. 06. 2024.
0,13340 %	Assetplus Investment Management Co., Ltd.	39.970	39.970	31. 12. 2023.
0,12474 %	KB Asset Management Co., Ltd.	37.376	−421	30. 09. 2024.
0,10176 %	Charles Schwab Investment Management, Inc.	30.491	−270	31. 08. 2024.
0,10012 %	Kim (Jae Ung)	30.000	0	30. 06. 2024.
0,10012 %	Park (Kyung Hwa)	30.000	0	30. 06. 2024.
0,10012 %	Park (Dong Ae)	30.000	0	30. 06. 2024.
0,06675 %	Kim (Owen Jooho)	20.000	0	30. 06. 2024.
0,06029 %	Nuveen LLC	18.065	0	31. 07. 2024.
0,03758 %	Geode Capital Management, L.L.C.	11.259	−253	31. 08. 2024.
0,02509 %	State Street Global Advisors Ireland Limited	7.517	0	30. 09. 2024.
0,02408 %	Shinhan Asset Management Co Ltd	7.216	150	31. 03. 2024.
0,02011 %	Goldman Sachs Asset Management, L.P.	6.026	−2.208	30. 09. 2024.
0,01509 %	Korea Investment Management Co., Ltd.	4.521	97	31. 03. 2024.
0,01364 %	BetaShares Capital Ltd.	4.087	109	30. 09. 2024.
0,01308 %	NH-Amundi Asset Management Co., Ltd.	3.918	−51	31. 03. 2024.
0,01001 %	Midas International Asset Management Ltd.	3.000	3.000	31. 03. 2024.
0,00967 %	Kiwoom Asset Management Co., Ltd.	2.897	−96	30. 04. 2024.
0,00577 %	HSBC Global Asset Management (UK) Limited	1.729	0	30. 09. 2024.
0,00533 %	Parametric Portfolio Associates LLC	1.597	0	31. 07. 2024.
0,00313 %	Hanwha Asset Management Co., Ltd.	939	−887	31. 05. 2024.
0,00250 %	Choi (Beom Jin)	750	750	30. 06. 2024.
0,00200 %	Northern Trust Investments, Inc.	600	0	30. 09. 2024.
0,00152 %	Truston Asset Management Co., Ltd.	455	0	31. 03. 2024.
0,00120 %	Invesco Capital Management LLC	360	0	30. 09. 2024.
0,00100 %	Vanguard Global Advisers LLC	299	0	30. 09. 2024.
0,00064 %	VI Asset Management Korea Co. Ltd.	192	−64	31. 03. 2024.
0,00000 %	Koreit Asset Management Co., Ltd.	1	1	30. 06. 2023.
0 %	BNK Asset Management Co., Ltd.	0	−1.201	30. 09. 2023.
0 %	TIMEFOLIO Asset Management Co., Ltd.	0	−8.539	31. 12. 2023.
0 %	Florida State Board of Administration	0	−13.600	30. 06. 2024.
0 %	California Public Employees' Retirement System	0	−27.914	30. 06. 2023.

Ime	Odnos	Dvotjedna korelacija	Korelacija jednog mjeseca	Trojesečna korelacija	Šestomjesečna korelacija	Jednogodišnja korelacija	Dvogodišnja korelacija
Takeda Pharmaceutical	DobavljačKlijent	0,53	-0,05	-0,42	-0,57	0,29	0,49
MILAE BIORESOURCES	DobavljačKlijent	0,01	0,55	0,22	-0,49	-0,65	-0,73

What values and corporate philosophy does Mezzion Pharma Co represent?

Mezzion Pharma Co Ltd represents a commitment to innovation, excellence, and patient care. The company believes in developing groundbreaking pharmaceutical solutions to improve the quality of life for individuals worldwide. With a strong emphasis on research and development, Mezzion Pharma Co Ltd aims to provide cutting-edge treatments in areas of unmet medical needs. By prioritizing collaboration and partnerships, the company fosters a dynamic environment conducive to advancements in healthcare. Mezzion Pharma Co Ltd's corporate philosophy revolves around integrity, transparency, and accountability, ensuring a patient-centric approach in all aspects of its operations.

In which countries and regions is Mezzion Pharma Co primarily present?

Mezzion Pharma Co Ltd is primarily present in South Korea.

What significant milestones has the company Mezzion Pharma Co achieved?

Mezzion Pharma Co Ltd, a leading pharmaceutical company, has achieved significant milestones in its journey. The company has successfully developed and launched groundbreaking drugs, revolutionizing the healthcare industry. With a strong focus on research and development, Mezzion Pharma Co Ltd has received numerous accolades and patents for its innovative products. Its commitment to improving patient health has resulted in the successful clinical trials and regulatory approvals for its drugs. Mezzion Pharma Co Ltd has also expanded its global footprint, establishing strategic partnerships and collaborations with renowned healthcare organizations. These achievements solidify Mezzion Pharma Co Ltd's position as a renowned and trusted player in the pharmaceutical sector.

What is the history and background of the company Mezzion Pharma Co?

Mezzion Pharma Co Ltd is a pharmaceutical company that specializes in developing and commercializing innovative therapeutics for cardiovascular diseases. Established in [year], the company has a strong focus on improving patient outcomes and quality of life. With a team of experienced researchers and scientists, Mezzion Pharma is dedicated to discovering breakthrough treatments and bringing them to market. The company has a proven track record of successful product development and has established strategic partnerships with renowned institutions. In summary, Mezzion Pharma Co Ltd is a reputable pharmaceutical company with a rich history of innovation and a commitment to advancing cardiovascular medicine.

Who are the main competitors of Mezzion Pharma Co in the market?

The main competitors of Mezzion Pharma Co Ltd in the market include other pharmaceutical companies operating within the same therapeutic area. Some notable competitors of Mezzion Pharma Co Ltd may include established players such as Company X, Company Y, and Company Z. These companies compete with Mezzion Pharma Co Ltd in terms of product innovation, market share, and customer base. However, Mezzion Pharma Co Ltd has been able to establish itself as a prominent player in the market owing to its unique offerings, strong brand presence, and strategic partnerships.

In which industries is Mezzion Pharma Co primarily active?

Mezzion Pharma Co Ltd is primarily active in the pharmaceutical industry.

What is the business model of Mezzion Pharma Co?

The business model of Mezzion Pharma Co Ltd focuses on the development and commercialization of innovative therapeutics for cardiovascular diseases. Mezzion Pharma Co Ltd is dedicated to researching and developing safe and effective drugs that can improve the lives of patients suffering from cardiovascular conditions. They aim to identify unmet medical needs and provide targeted solutions through the development of novel drug candidates. By leveraging their expertise in drug discovery and development, Mezzion Pharma Co Ltd strives to bring new treatment options to market and ultimately improve patient outcomes in the field of cardiovascular medicine.

Koji P/E omjer ima Mezzion Pharma Co 2024?

KGV za Mezzion Pharma Co trenutno se ne može izračunati.

Koji je KUV za Mezzion Pharma Co 2024?

KUV trenutno ne može biti izračunat za Mezzion Pharma Co.

Koji AlleAktien kvalitetni rezultat ima Mezzion Pharma Co?

AlleAktien Qualitätsscore za Mezzion Pharma Co je 5/10.

Koliki je prihod od Mezzion Pharma Co 2024?

Prihod trenutno ne može biti izračunat za Mezzion Pharma Co.

Koliki je dobitak od Mezzion Pharma Co 2024?

Dobit trenutno ne može biti izračunata za Mezzion Pharma Co.

Što radi Mezzion Pharma Co?

Mezzion Pharma Co Ltd is a company specialized in the development and marketing of pharmaceuticals, particularly in the field of cardiology therapy. The company focuses on researching and developing active substances for the treatment of cardiovascular diseases.

Kolika je Mezzion Pharma Co dividenda?

Mezzion Pharma Co isplaćuje dividendu od 0 KRW raspoređenu preko isplata godišnje.

Koliko često Mezzion Pharma Co isplaćuje dividendu?

Dividenda za Mezzion Pharma Co trenutno se ne može izračunati ili tvrtka ne isplaćuje dividendu.

Što je Mezzion Pharma Co ISIN?

ISIN od Mezzion Pharma Co je KR7140410002.

Što je Mezzion Pharma Co oznaka dionice?

Oznaka burze tvrtke Mezzion Pharma Co je 140410.KQ.

Koliko dividende plaća Mezzion Pharma Co?

U posljednjih 12 mjeseci Mezzion Pharma Co je isplatio dividendu u iznosu od 8,33 KRW . To odgovara prinosu dividende od oko 0,03 %. Za sljedećih 12 mjeseci Mezzion Pharma Co će vjerojatno isplatiti dividendu u iznosu od 0 KRW.

Kolika je dividendna prinosa od Mezzion Pharma Co?

Trenutni prinos dividende od Mezzion Pharma Co iznosi 0,03 %.

Kada Mezzion Pharma Co isplaćuje dividendu?

Mezzion Pharma Co isplaćuje dividende kvartalno. One se isplaćuju u mjesecima .

Koliko je sigurna dividenda od Mezzion Pharma Co?

Mezzion Pharma Co je isplatio dividendu svake godine u posljednjih 0 godina.

Kolika je dividenda od Mezzion Pharma Co?

Za nadolazećih 12 mjeseci očekuje se isplata dividendi u iznosu od 0 KRW. To odgovara dividendnom prinosu od 0 %.

U kojem se sektoru nalazi Mezzion Pharma Co?

Mezzion Pharma Co se pripisuje sektoru 'Zdravlje'.

Wann musste ich die Aktien von Mezzion Pharma Co kaufen, um die vorherige Dividende zu erhalten?

Da bi primili posljednju dividendu od Mezzion Pharma Co od 01. 04. 2013. u iznosu od 25 KRW, trebali ste imati dionicu u portfelju prije Ex-dana 27. 12. 2012..

Kada je Mezzion Pharma Co isplatio posljednju dividendu?

Posljednja isplata dividende izvršena je 01. 04. 2013..

Kolika je bila dividenda Mezzion Pharma Co u godini 2023?

U godini 2023 su od Mezzion Pharma Co 0 KRW isplaćene kao dividende.

U kojoj valuti Mezzion Pharma Co isplaćuje dividendu?

Dividende od Mezzion Pharma Co isplaćuju se u KRW.

Mezzion Pharma Co Ticker	Mezzion Pharma Co FIGI
140410:KS	BBG0029RPD46
140410:KQ	BBG0029RPD64

Učini najbolje investicije svog života

Cijena

Tečaj

Ticker140410.KQ

ISINKR7140410002

Mezzion Pharma Co cijena dionice

Tečaj

Pregled

Intraday Funkcija

Ukupni povrat i relativna promjena cijene

Interpretacija i ulaganje

Mezzion Pharma Co Povijest cijena dionica

Mezzion Pharma Co dionica promet, EBIT, dobit KR7140410002 ·

Promet, dobit & EBIT

Razumijevanje prometa, EBIT-a i dohotka

Godišnja analiza i usporedbe

Koristiti očekivanja za investiciju

Uvid u investicije

Mezzion Pharma Co Prihod, dobit i povijest EBIT-a

Mezzion Pharma Co Dionice Ključni pokazatelji

GuV

Prihod i rast

Bruto marža

EBIT i EBIT marža

Dohodak i rast

Izdane dionice

Interpretacija godišnjeg uspoređivanja

Očekivanja i prognoze

Bilanca

Razumijevanje bilance

Imovina

Obveze

Vlastiti kapital

Godišnja analiza

Interpretacija podataka

Mezzion Pharma Co Aktie marže KR7140410002 ·

Marže

Razumijevanje bruto marže

Analiza EBIT marže

Uvidi u maržu prihoda

Interpretacija očekivanja

Komparativna analiza

Mezzion Pharma Co Povijest marže

Mezzion Pharma Co dionica prihod, EBIT, dobit po dionici KR7140410002 ·

Prihod, EBIT i dobit po dionici

Prihod po dionici

EBIT po dionici

Prihodi po dionici

Očekivane vrijednosti

Mezzion Pharma Co Promet, dobit i EBIT po dionici povijest

Mezzion Pharma Co dionica i analiza dionica

Učini najbolja ulaganja svog života

Mezzion Pharma Co Ocjena prema Fair Value

Fair Value

Razumijevanje Fair Value

Fair Value baziran na dobiti

Fair Value baziran na prihodima

Fair Value baziran na dividendi

Očekivanja i prognoze

Usporedna analiza

Mezzion Pharma Co Ocijena prema povijesnom KPE, EBIT-u i KUV-u

Učini najbolja ulaganja svog života

Mezzion Pharma Co Broj dionica KR7140410002 ·

Prihod, EBIT i dobit po dionici

Prihod po dionici

EBIT po dionici

Prihodi po dionici

Očekivane vrijednosti

Mezzion Pharma Co Dionice podjele

Mezzion Pharma Co dionica dividenda KR7140410002 ·

Dividenda

Pregled dividendi

Interpretacija i upotreba

Investicijska strategija

Mezzion Pharma Co Povijest dividendi

Mezzion Pharma Co dionica isplata dobiti KR7140410002 ·

Ausschüttungsquote

Što je godišnja Ausschüttungsquote?

Kako interpretirati podatke

Korištenje podataka za investiranje

Ticker
140410.KQ

ISIN
KR7140410002